Christopher Exley, PhD, Professor in Bioinorganic Chemistry at Keele University, and Leader of the Research Group on Aluminium and Silicon, He is a Fellow of the Royal Society of Biology (FRSB), Scientific Member of the British Society of Ecological Medicine (BSEM).
Dr. Exley is recognized as a world-renowned expert on Aluminum toxicity and aluminum in the human brain. His research has been published in approximately 190 peer-reviewed journals. He has authored twelve chapters in books, and edited compilations on aluminium : aluminium in biological systems, aluminium in medicine, aluminium in Alzheimer’s disease, and aluminium in the human brain.
Dr. Exley’s publications are listed here. Dr. Exley’s most recent journal articles include:
“Currently about 20 childhood vaccines include an aluminium adjuvant. The aluminium salt is the major component of a vaccine (after water) and its high content is why vaccine preparations are invariably cloudy in appearance . As an example, GlaxoSmithKline’s Infanrix Hexa vaccine is reported by the manufacturer to contain 0.82 mg of aluminium per vaccine (0.5 mL). Thus, the weight of aluminium salt in this vaccine is approximately 8 mg, which is approximately ten times the weight of all of the other components of the vaccine when combined. An aluminium-adjuvanted vaccine is essentially a very high concentration of an aluminium salt.”